COURTNEY GATES: Open Payments
NPI 1780281691 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 29 payments from 7 companies in 2025. Trend: 2023 $549 · 2024 $1,398 · 2025 $916
Food & beverage: $784Education: $132
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $289 |
| AstraZeneca Pharmaceuticals LP | 9 | $199 |
| Amgen Inc. | 6 | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Alexion Pharmaceuticals, Inc. | 1 | $28 |
| Vifor Pharma, Inc. | 1 | $25 |
Products named: Ozempic, FARXIGA, KRYSTEXXA, JARDIANCE, Kerendia, ULTOMIRIS, Veltassa.
Industry payments across HI — which companies pay providers there.
